TOPARP-B: A phase II randomised trial of the poly(ADP)-ribose polymerase (PARP)inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations
Authors
Mateo, JPorta, N
McGovern, U
Elliott, Tony
Jones, R
Syndikus, I
Ralph, C
Jain, S
Varughese, M
Parikh, O
Crabb, S
Robinson, A
McLaren, D
Birtle, A
Tanguay, J
Miranda, S
Seed, G
Bertan, C
Espinasse, A
Chatfield, P
Bianchini, D
Hall, E
Carreira, S
De Bono, J
Affiliation
Vall dÕHebron Institute of Oncology, Barcelona, SpainIssue Date
2019